How Consumers Can Report an Adverse Event or Serious Problem to FDA: MedWatch is the Food and Drug Administration's (FDA) program for reporting serious reactions, product quality problems, therapeutic inequivalence/failure, and product use errors with human medical products, including drugs, biologic products, medical devices, dietary supplements, infant formula, and cosmetics.

How Consumers Can Report an Adverse Event or Serious Problem to FDA: MedWatch is the Food and Drug Administration's (FDA) program for reporting serious reactions, product quality problems, therapeutic inequivalence/failure, and product use errors with human medical products, including drugs, biologic products, medical devices, dietary supplements, infant formula, and cosmetics.

The group is coordinated by Manuel Guzmán. Nowadays, Ismael Galve-Roperh, Cristina Sánchez and Guillermo Velasco coordinate three of the ongoing research lines in our group.        Currently, the major focus of our group is the study of the mechanisms by which cannabinoids – the active components of Cannabis sativa L. – and their endogenous counterparts control the proliferation, differentiation and survival of different types of cells.

The group is coordinated by Manuel Guzmán. Nowadays, Ismael Galve-Roperh, Cristina Sánchez and Guillermo Velasco coordinate three of the ongoing research lines in our group. Currently, the major focus of our group is the study of the mechanisms by which cannabinoids – the active components of Cannabis sativa L. – and their endogenous counterparts control the proliferation, differentiation and survival of different types of cells.

Iron Man de eerst deel van de trilogie

Iron Man (2008)

Iron Man de eerst deel van de trilogie

Also called yogurt cheese, labneh is a delicious Middle Eastern fermented food that can be used in various ways — make your own labneh at home today. http://recipes.mercola.com/homemade-labneh-recipe.aspx

Also called yogurt cheese, labneh is a delicious Middle Eastern fermented food that can be used in various ways — make your own labneh at home today. http://recipes.mercola.com/homemade-labneh-recipe.aspx

Didáctica. Lengua y Literatura. UCM.

Didáctica. Lengua y Literatura. UCM.

Compulab makes a line of tiny desktop computers that it sells under the Fit-PC brand, among others. But the company also offers a line of computer-on-modules including solutions with Intel and AMD chips, and tiny models with ARM-based chips from Freescale/NXP.  The company's latest ARM-based module is called the UCM-iMX7 and it features a Cortex-A7 processor, up to 2GB of RAM, up to 32GB of storage, and integrated WiFi, Bluetooth, and Ethernet support.  It also measures just 30mm x 2...

Compulab makes a line of tiny desktop computers that it sells under the Fit-PC brand, among others. But the company also offers a line of computer-on-modules including solutions with Intel and AMD chips, and tiny models with ARM-based chips from Freescale/NXP. The company's latest ARM-based module is called the UCM-iMX7 and it features a Cortex-A7 processor, up to 2GB of RAM, up to 32GB of storage, and integrated WiFi, Bluetooth, and Ethernet support. It also measures just 30mm x 2...

Story of the Season January 2014 - ESPN the Magazine

Story of the Season January 2014 - ESPN the Magazine

Approved Products > Complete List of Vaccines Licensed for Immunization and Distribution in the US

Approved Products > Complete List of Vaccines Licensed for Immunization and Distribution in the US

Short Film Reveals Fluoride's Side Effects

Short Film Reveals Fluoride's Side Effects

March 10, 2015: "FDA approves first therapy for high-risk neuroblastoma - The U.S. Food and Drug Administration today approved Unituxin (dinutuximab) as part of first-line therapy for pediatric patients with high-risk neuroblastoma, a type of cancer that most often occurs in young children."   Click the link to read more:  http://www.fda.gov/…/Newsr…/PressAnnouncements/ucm437460.htm

March 10, 2015: "FDA approves first therapy for high-risk neuroblastoma - The U.S. Food and Drug Administration today approved Unituxin (dinutuximab) as part of first-line therapy for pediatric patients with high-risk neuroblastoma, a type of cancer that most often occurs in young children." Click the link to read more: http://www.fda.gov/…/Newsr…/PressAnnouncements/ucm437460.htm

Pinterest
Buscar